A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2017
At a glance
- Drugs ARRY 797 (Primary)
- Indications Cardiomyopathies
- Focus Adverse reactions
- Sponsors Array BioPharma
- 09 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 04 Feb 2015 New trial record
- 02 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.